- 期刊
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells
延伸閱讀
- Wagner, E. R., Luther, G., Zhu, G., Luo, Q., Shi, Q., Kim, S. H., Gao, J. L., Huang, E., Gao, Y., Yang, K., Wang, L., Teven, C., Luo, X., Liu, X., Li, M., Hu, N., Su, Y., Bi, Y., He, B. C., Tang, N., Luo, J., Chen, L., Zuo, G., Rames, R., Haydon, R. C., Luu, H. H., & He, T. C. (2011). Defective Osteogenic Differentiation in the Development of Osteosarcoma. Sarcoma, 2011(), 116-127. https://doi.org/10.1155/2011/325238
- Li, S. M. (2007). Effect of demethylation and histone deacetylase inhibitors on differential expression of genes in human ovarian cancer andchoriocarcinoma cell lines [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200018046
- Kam, K. (2007). Therapeutic potential of demethylation agents and histone deaceytlase inhibitors in NK-cell lymphoma and leukemia [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200017936
- 李嘉華（2013）。Anticancer activity of the novel histone deacetylase inhibitor, MPT0G028, in human colorectal cancer cells in vitro and in vivo〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2013.11230
- Arlt, M. J. E., Banke, I. J., Bertz, J., Kumar, R. M. R., Muff, R., Born, W., & Fuchs, B. (2013). Reduced Latency in the Metastatic Niche Contributes to the More Aggressive Phenotype of LM8 Compared to Dunn Osteosarcoma Cells. Sarcoma, 2013(), 125-137. https://doi.org/10.1155/2013/404962